secwatch.observer — SEC 8-K summary
======================================

Issuer:     IO Biotech, Inc. (IOBTQ)
CIK:        0001865494
Form:       8-K
Filed at:   2025-06-09T23:59:59+00:00
Accession:  0001193125-25-137894
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

IO Biotech stockholders elect David Smith to board, ratify EY as auditor
------------------------------------------------------------------------

- David Smith elected as Class I director with 40,444,898 votes for, 3,010,542 withheld, 8,622,498 broker non-votes.
- Ratification of EY Godkendt Revisionspartnerselskab as independent auditor: 51,581,966 for, 183,927 against, 312,045 abstain.
- Annual Meeting held June 5, 2025; both proposals approved.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1865494/000119312525137894/0001193125-25-137894-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1865494/000119312525137894/d908239d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-137894

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer